YARROW BIOSCIENCE, INC. Cost of Revenue
YARROW BIOSCIENCE, INC. (YARW) reported Cost of Revenue of $3.35 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-17.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2022-03-17
- YARROW BIOSCIENCE, INC. cost of goods and services sold for the quarter ending 2021-12-31 was $903.00K, a 69.10% increase year-over-year.
- YARROW BIOSCIENCE, INC. cost of goods and services sold for the quarter ending 2021-09-30 was $1.05M, a 182.75% increase year-over-year.
- YARROW BIOSCIENCE, INC. cost of goods and services sold for the quarter ending 2021-06-30 was $795.00K, a 268.06% increase year-over-year.
- YARROW BIOSCIENCE, INC. cost of goods and services sold for the quarter ending 2021-03-31 was $601.00K, a 121.77% increase year-over-year.
- YARROW BIOSCIENCE, INC. cost of goods and services sold for fiscal 2021 was $3.35M, a 140.52% increase from fiscal 2020.
- YARROW BIOSCIENCE, INC. cost of goods and services sold for fiscal 2020 was $1.39M.
- YARROW BIOSCIENCE, INC. cost of goods and services sold for fiscal 2019 was $0.00.
- YARROW BIOSCIENCE, INC. cost of goods and services sold for fiscal 2018 was $0.00.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2021-12-31 | $903.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $1.95M derived: sum of 2 quarters · filed 2022-03-17 | $2.75M derived: sum of 3 quarters · filed 2022-03-17 | $3.35M 10-K · filed 2022-03-17 |
| 2021-09-30 | $1.05M 10-Q · filed 2021-11-10 | $1.84M derived: sum of 2 quarters · filed 2021-11-10 | $2.44M 10-Q · filed 2021-11-10 | $2.98M derived: sum of 4 quarters · filed 2022-03-17 |
| 2021-06-30 | $795.00K 10-Q · filed 2021-08-12 | $1.40M 10-Q · filed 2021-08-12 | $1.93M derived: sum of 3 quarters · filed 2022-03-17 | $2.30M derived: sum of 4 quarters · filed 2022-03-17 |
| 2021-03-31 | $601.00K 10-Q · filed 2021-05-06 | $1.14M derived: sum of 2 quarters · filed 2022-03-17 | $1.51M derived: sum of 3 quarters · filed 2022-03-17 | $1.72M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-12-31 | $534.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $905.00K derived: sum of 2 quarters · filed 2022-03-17 | $1.12M derived: sum of 3 quarters · filed 2022-03-17 | $1.39M 10-K · filed 2022-03-17 |
| 2020-09-30 | $371.00K 10-Q · filed 2021-11-10 | $587.00K derived: sum of 2 quarters · filed 2021-11-10 | $858.00K 10-Q · filed 2021-11-10 | $858.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $216.00K 10-Q · filed 2021-08-12 | $487.00K 10-Q · filed 2021-08-12 | $487.00K derived: sum of 3 quarters · filed 2021-08-12 | $487.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $271.00K 10-Q · filed 2021-05-06 | $271.00K derived: sum of 2 quarters · filed 2021-05-06 | $271.00K derived: sum of 3 quarters · filed 2021-05-06 | $271.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $0.00 derived: sum of 2 quarters · filed 2021-03-04 | $0.00 derived: sum of 3 quarters · filed 2021-03-04 | $0.00 10-K · filed 2021-03-04 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |